Recent advances in pruritus - What we have learned and where are we headed

F1000 Medicine Reports

Volumn 2, Issue 1, 2010, Pages

  Yosipovitch, Gil ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CATHEPSIN S; CORTICOSTEROID; GASTRIN RELEASING PEPTIDE RECEPTOR; INTERLEUKIN 31; NALFURAFINE; NALTREXONE; NEUROKININ; PREGABALIN; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4;

ATOPIC DERMATITIS; BURNING SENSATION; CLINICAL TRIAL; HUMAN; NOCICEPTION; PROTEIN EXPRESSION; PRURIGO; PRURITUS; QUALITY OF LIFE; REVIEW;

EID: 77955075844     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M2-39     Document Type: Review

References (26)

1. Weisshaar E, Dalgard F: Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol 2009, 89:339-50.
2. Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK: Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006, 21:3495-505.
3. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE: Specific C-receptors for itch in human skin. J Neurosci 1997, 17:8003-8.
4. Andrew D, Craig AD: Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 2001, 4:72-7.
5. Johanek LM, Meyer RA, Friedman RM, Greenquist KW, Shim B, Borzan J, Hartke T, LaMotte RH, Ringkamp M: A role for polymodal C-fiber afferents in nonhistaminergic itch. J Neurosci 2008, 28:7659-69.
6. Davidson S, Zhang X, Yoon CH, Khasabov SG, Simone DA, Giesler GJ Jr: The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci 2007, 27:10007-14.
7. Namer B, Carr R, Johanek LM, Schmelz M, Handwerker HO, Ringkamp M: Separate peripheral pathways for pruritus in man. J Neurophysiol 2008, 100:2062-9.
8. Reddy B: Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J Neurosci 2008, 28:4331-5.
9. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, Schmelz M: Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003, 23:6176-80.
10. Reddy VB, Shimada SG, Sikand P, Lamotte RH, Lerner EA: Cathepsin S elicits itch and signals via protease-activated receptors. J Invest Dermatol 2010, 130:1468-70.
11. Sun YG, Chen ZF: A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 2007, 448:700-3.
12. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF: Cellular basis of itch sensation. Science 2009, 325:1531-4.
13. Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, Ru F, Guan Y, Weng HJ, Geng Y, Undem BJ, Kollarik M, Chen ZF, Anderson DJ, Dong X: Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 2009, 139:1353-65.
14. Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA: New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol 2009, 161:1217-24.
15. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B: IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006, 117:411-7.
16. Grimstad O, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen UB, Grønhøj-Larsen C, Matsushima K: Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 2009, 18:35-51.
17. Kumagai H, Saruta T, Matsukawa S, Utsumi J: Prospects for a novel kappa-opioid receptor agonist, TRK-820, in uremic pruritus. In Itch: Basic Mechanisms and Therapy. Edited by Yosipovitch G, Greaves MW, Fleischer JA, McGlone F. New York: Dekker; 2004:279-86.
18. Bigliardi PL, Tobin DJ, Gaveriaux-Ruff C, Bigliardi-Qi M: Opioids and the skin - where do we stand? Exp Dermatol 2009, 18:424-30.
19. Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H: Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 2010, 25:1251-7.
20. Yosipovitch G, Carstens E, McGlone F: Chronic itch and chronic pain: analogous mechanisms. Pain 2007, 131:4-7.
21. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M: The neurobiology of itch. Nat Rev Neurosci 2006, 7:535-47.
22. Shim WS, Tak MH, Lee MH, Kim M, Kim M, Koo JY, Lee CH, Kim M, Oh U: TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 2007, 27:2331-7.
23. Imamachi N, Park GH, Lee H, Anderson DJ, Simon MI, Basbaum AI, Han SK: TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci U S A 2009, 106:11330-5.
24. Carstens E, Carstens ML, Simone CT, Jinks S: Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats. Neuroreport 2010, 21:303-8.
25. Ishiuji Y, Coghill RC, Patel TS, Oshiro Y, Kraft RA, Yosipovitch G: Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol 2009, 161:1072-80.
26. Summey BT Jr, Yosipovitch G: Pharmacologic advances in the systemic treatment of itch. Dermatol Ther 2005, 18:328-32.